Claudia Mosillo

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

Alessio Cortellini, Melissa Bersanelli, Daniele Santini et al. · European Journal of Cancer · 2020 · 125 citations

Life Sciences, Immunology, Oncology +17

Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney

Emanuela Risi, Roberto Iacovelli, Amelia Altavilla et al. · Urology · 2013 · 82 citations

Medicine, Oncology, Pathology +14

Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer

Roberto Iacovelli, Chiara Ciccarese, Claudia Mosillo et al. · Targeted Oncology · 2018 · 27 citations

Medicine, Oncology, Urology +12

Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives

Matteo Bauckneht, Chiara Ciccarese, Riccardo Laudicella et al. · Cancer Treatment Reviews · 2024 · 27 citations · Full text

Medicine, Oncology, Translational Sciences +17

Cabozantinib‐related cardiotoxicity: a prospective analysis in a <i>real‐world</i> cohort of metastatic renal cell carcinoma patients

Roberto Iacovelli, Chiara Ciccarese, Giuseppe Fornarini et al. · British Journal of Clinical Pharmacology · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17